Skip to main content
. 2012 Sep 16;9:201. doi: 10.1186/1743-422X-9-201

Figure 1.

Figure 1

Reactivity of camel IgGs and human IVIG-1, IVIG-2 and IVIG-3 against HCV synthetic peptides 1–6 (A-F), in serial dilutions.